Lantheus Holdings, Inc. (LNTH) has a MoatMap StockRank of 97/100 based on Quality (74/100), Value (43/100), and Momentum (69/100) factor scores. The current signal is STRONG BUY. Lantheus Holdings, Inc., a US healthcare company specializing in radiopharmaceuticals and diagnostic agents, could be a quality business with strong IP and pricing power in specialized niches. However, it lacks a clear, asymmetric macro tailwind from the identified themes that would create an unpriced opportunity for significant outperformance.